1.
Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?
by Caraci, Filippo
Current medical research and opinion, 2020, Vol.36 (6), p.1015-1024
2.
Tapentadol prolonged release for managing moderate to severe chronic neck pain with or without a neuropathic component
by Coluzzi, Flaminia
Current medical research and opinion, 2020, Vol.36 (4), p.651-659
3.
Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain
by Sánchez del Águila, Manuel J., FCARCSI
Clinical therapeutics, 2015, Vol.37 (1), p.94-113
4.
The painDETECT project - far more than a screening tool on neuropathic pain
by Freynhagen, Rainer
Current medical research and opinion, 2016, Vol.32 (6), p.1033-1057
5.
Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline
by Müller-Lissner, Stefan
Pain medicine (Malden, Mass.), 2017, Vol.18 (10), p.1837-1863
6.
Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials
by Freynhagen, R.
Current medical research and opinion, 2021, Vol.37 (1), p.89-100
7.
Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?
by Caraci, Filippo
Current medical research and opinion, 2020, Vol.36 (5), p.I-XVII
8.
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
by Schwartz, Sherwyn
Current medical research and opinion, 2011, Vol.27 (1), p.151-162
9.
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of...
by Lange, Bernd
Current medical research and opinion, 2018, Vol.34 (12), p.2113-2123
10.
Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries
by Wang, Xinyi
Current medical research and opinion, 2022, Vol.38 (1), p.115-121
11.
A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section: Tapentadol vs. oxycodone post elective cesarean section
by Ffrench-O'Carroll, R.
Current medical research and opinion, 2019, Vol.35 (6), p.975-981
12.
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
by Daniels, Stephen E
Current medical research and opinion, 2009, Vol.25 (3), p.765-776
13.
The role of tapentadol as a strong opioid in cancer pain management: a systematic and critical review
by Mercadante, Sebastiano
Current medical research and opinion, 2017, Vol.33 (11), p.1965-1969
14.
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extens...
by Buynak, Robert, MD
Clinical therapeutics, 2015, Vol.37 (11), p.2420-2438
15.
Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment
by Butler, Stephen F.
Pain medicine (Malden, Mass.), 2015, Vol.16 (1), p.119-130
16.
Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study
by Hale, Martin
Current medical research and opinion, 2009, Vol.25 (5), p.1095-1104
17.
Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms
by Müller-Schwefe, Gerhard
Current medical research and opinion, 2017, Vol.33 (7), p.1199-1210
18.
Tapentadol in cancer pain management: a prospective open-label study
by Mercadante, Sebastiano
Current medical research and opinion, 2012, Vol.28 (11), p.1775-1779
19.
Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain
by Imanaka, Keiichiro
Current medical research and opinion, 2013, Vol.29 (10), p.1399-1409
20.
Systematic review of tapentadol in chronic severe pain
by Riemsma, Rob
Current medical research and opinion, 2011, Vol.27 (10), p.1907-1930
